Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on New Mexico Tech Monitor.
Press releases published on April 21, 2025
ORYZON Continues to Strengthen its Patent Portfolio for Vafidemstat
GlobeNewswire
·
April 21, 2025
MADRID and CAMBRIDGE, Mass., April 21, 2025 (GLOBE NEWSWIRE) -- Oryzon Genomics, S.A. (ISIN Code: ES0167733015, ORY), a clinical-stage biopharmaceutical company and a European leader in epigenetics, announced today that the European Patent Office has …
Tempest Receives Orphan Drug Designation from the FDA for TPST-1495 to Treat Patients with FAP
GlobeNewswire
·
April 21, 2025
BRISBANE, Calif., April 21, 2025 (GLOBE NEWSWIRE) -- Tempest Therapeutics, Inc. (Nasdaq: TPST), a clinical-stage biotechnology company developing first-in-class1 targeted and immune-mediated therapeutics to fight cancer, today announced that the U.S. Food …
Reflect Scientific Inc. Announces Strategic Market Transition and Substantial Cost Savings
GlobeNewswire
·
April 21, 2025
OREM, Utah, April 21, 2025 (GLOBE NEWSWIRE) -- Reflect Scientific Inc. (symbol: RSCF), a leading innovator in advanced refrigeration and cooling technologies, today announced significant financial improvements resulting from strategic market transitions …
Snail Games Subsidiary Interactive Films LLC Signs MOU with Mega Matrix Inc. (NYSE American: MPU) for Joint Short-Drama Development
GlobeNewswire
·
April 21, 2025
CULVER CITY, Calif., April 21, 2025 (GLOBE NEWSWIRE) -- Snail, Inc. (Nasdaq: SNAL) (“Snail Games” or the “Company”), a leading global independent developer and publisher of interactive digital entertainment, announced that its wholly owned subsidiary, …
Elutia Initiates EluPro™ Registry Study Designed to Generate Evidence Supporting the Use of EluPro in Real-World Clinical Practice
GlobeNewswire
·
April 21, 2025
— Integration of clinical and patient-reported outcomes expected to further differentiate EluPro’s utility in cardiac implantable electronic device (CIED) procedures — SILVER SPRING, Md., April 21, 2025 (GLOBE NEWSWIRE) -- Elutia Inc. (Nasdaq: ELUT) (“ …
Chemomab Therapeutics to Present Nebokitug Clinical Data at Upcoming Scientific Conferences
GlobeNewswire
·
April 21, 2025
TEL AVIV, Israel, April 21, 2025 (GLOBE NEWSWIRE) -- Chemomab Therapeutics, Ltd., (Nasdaq: CMMB), a clinical stage biotechnology company developing innovative therapeutics for fibro-inflammatory diseases with high unmet need, today announced that clinical …
SoftBank Chain (SBC) Launches Interstellar: Powering the Future of Web3 Payments and Open Finance
GlobeNewswire
·
April 21, 2025
New York, NY, April 21, 2025 (GLOBE NEWSWIRE) -- SoftBank Chain (SBC) has officially launched Interstellar, a groundbreaking solution designed to revolutionize Web3 payments and open finance infrastructure. As a next-generation protocol, Interstellar aims …
Kraig Biocraft Laboratories Provides Production Update on Recombinant Spider Silk Operations
GlobeNewswire
·
April 21, 2025
ANN ARBOR, Mich., April 21, 2025 (GLOBE NEWSWIRE) -- Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) ("the Company" or "Kraig Labs"), a world leader in spider silk technology*, is pleased to provide an update on recombinant spider silk production. The …
Invivyd Announces $30M Non-dilutive Loan Facility with Silicon Valley Bank
GlobeNewswire
·
April 21, 2025
WALTHAM, Mass., April 21, 2025 (GLOBE NEWSWIRE) -- Invivyd, Inc. (Nasdaq: IVVD), a biopharmaceutical company devoted to delivering protection from serious viral infectious diseases, today announced that it has signed a $30 million term loan facility with …
Arvinas to Present Preclinical Data for PROTAC BCL6 Degrader, ARV-393, at 2025 American Association for Cancer Research® (AACR) Annual Meeting
GlobeNewswire
·
April 21, 2025
NEW HAVEN, Conn., April 21, 2025 (GLOBE NEWSWIRE) -- Arvinas, Inc. (Nasdaq: ARVN), a clinical-stage biotechnology company working to develop a new class of drugs based on targeted protein degradation, today announced that new preclinical combination data …
BioCryst to Report First Quarter 2025 Financial Results on May 5
GlobeNewswire
·
April 21, 2025
RESEARCH TRIANGLE PARK, N.C., April 21, 2025 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that the company will report its first quarter 2025 financial results on Monday, May 5, 2025. BioCryst management will host a …
Ascentage Pharma Announces Inclusion of Lisaftoclax and Olverembatinib in Chinese Society of Clinical Oncology (CSCO) 2025 Guidelines
GlobeNewswire
·
April 21, 2025
ROCKVILLE, Md. and SUZHOU, China, April 21, 2025 (GLOBE NEWSWIRE) -- Ascentage Pharma (NASDAQ: AAPG; HKEX: 6855), a global biopharmaceutical company engaged in discovering, developing, and commercializing therapies to address global unmet medical needs …
AccuStem Sciences, Inc. Announces Chairman Purchase of Shares
GlobeNewswire
·
April 21, 2025
LONDON and PHOENIX, Ariz., April 21, 2025 (GLOBE NEWSWIRE) -- AccuStem Sciences, Inc. (OTCQB: ACUT), a clinical stage diagnostics company dedicated to improving outcomes for patients with cancer, announced that its Chairman of the Board, Mr. Gabriele …
Amicus Therapeutics to Announce First Quarter 2025 Financial Results on May 1, 2025
GlobeNewswire
·
April 21, 2025
PRINCETON, N.J., April 21, 2025 (GLOBE NEWSWIRE) -- Amicus Therapeutics (Nasdaq: FOLD) today announced that the Company will host a conference call and live audio webcast on Thursday, May 1, 2025, at 8:30 a.m. ET to discuss financial results for the first …
Apellis Announces Craig Wheeler to Join the Board of Directors
GlobeNewswire
·
April 21, 2025
WALTHAM, Mass., April 21, 2025 (GLOBE NEWSWIRE) -- Apellis Pharmaceuticals, Inc. (Nasdaq: APLS) today announced that Craig Wheeler, founder and chief executive officer of Headwaters Biotech Advisors, will join the Apellis Board of Directors, effective …
Salary.com to Present with Gonzaga University at CUPA-HR Spring Conference
GlobeNewswire
·
April 21, 2025
WALTHAM, Mass., April 21, 2025 (GLOBE NEWSWIRE) -- WHO: Garry Straker, Vice President of Compensation Consulting at Salary.com, a leading provider of compensation market data and software WHAT: Will join Kelsey Gregory, Compensation Analyst, and Kelly …
Immunovant Announces Next Phase of Growth with Roivant Including Changes to its Leadership Team and Additional Indications Sjögren’s Disease (SjD) and Cutaneous Lupus Erythematosus (CLE) for IMVT-1402
GlobeNewswire
·
April 21, 2025
Eric Venker, M.D. (currently President and COO of Roivant) appointed as CEO of Immunovant and Tiago Girao appointed as CFO of Immunovant Pete Salzmann, M.D. retired from his role as Immunovant CEO and Director Leadership change is part of a broader …
Immunovant Announces Next Phase of Growth with Roivant Including Changes to its Leadership Team and Additional Indications Sjögren’s Disease (SjD) and Cutaneous Lupus Erythematosus (CLE) for IMVT-1402
GlobeNewswire
·
April 21, 2025
Eric Venker, M.D. (currently President and COO of Roivant) appointed as CEO of Immunovant and Tiago Girao appointed as CFO of Immunovant Pete Salzmann, M.D. retired from his role as Immunovant CEO and Director Leadership change is part of a broader …
Cryptocurrency has quietly become the preferred asset reserve for investment, and KSD Miner is very popular among users around the world.
GlobeNewswire
·
April 21, 2025
London, UK, April 21, 2025 (GLOBE NEWSWIRE) -- From Change to Big Cash: How to Make $1 Million with $100 in 2025 As times have changed, Will the US tariffs lead to a depreciation of the US dollar? Cryptocurrency has quietly become the preferred asset …
Elixir AI Blazes into Web3 — Achieves 10x Growth on Launch Day
GlobeNewswire
·
April 21, 2025
New York, NY, April 21, 2025 (GLOBE NEWSWIRE) -- In just 24 hours, Elixir AI made waves across the crypto world. Officially launched on April 19, the AI-powered 3D content generation platform saw its native token $ELXAI skyrocket by 10x, signaling early …